In vitro macrophage endotoxin tolerance: Defective in vitro macrophage MAP kinase signal transduction after LPS pretreatment is not present in macrophages from C3H/HeJ endotoxin resistant mice

Shock

Volumn 11, Issue 1, 1999, Pages 58-63

  Kraatz, James ^a   Clair, Laurel ^a   Rodriguez, Jorge L ^a   West, Michael A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYTOKINE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE (CALCIUM,CALMODULIN); SH2D1A PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYMOLOGY; MACROPHAGE; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CYTOKINES; DRUG RESISTANCE; ENZYME ACTIVATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C3H; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE TISSUE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TETRADECANOYLPHORBOL ACETATE;

EID: 0032621649     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199901000-00009     Document Type: Article

References (35)

1. Beal AL, Cerra FB: Multiple Organ Failure Syndrome in the 1990's. JAMA 271:226-233, 1994.
2. Bone RC: Sepsis and its complications: The clinical problem. Crit Care Med 22:S8-12, 1994.
3. Glauser MP, Heumann D, Baumgartner JD, Cohen J: Pathogenesis and potential strategies for prevention and treatment of septic shock: An update. Clin Infect Dis 18:S205-216, 1994.
4. West MA, Baker J, Bellingham J, Clair L: Discordant reprogramming of LPS-stimulated cytokine gene transcription and secretion by macrophages after LPS pretreatment. J Surg Res 63:209-214, 1996.
5. West MA, LeMieur T, Clair L, Bellingham J, Rodriguez JL: Protein kinase C regulates macrophage tumor necrosis factor secretion: Direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance. Surgery 122:204-212, 1997.
6. Johnston CA, Greisman SE: Mechanisms of endotoxin tolerance. In Proctor RA and Hinshaw LB: Pathophysiology of Endotoxin, Vol. 2. Amsterdam: Elsevier Science Publishers,1985, pp 235-401.
7. Sanchez-Cantu L, Rode HN, Christou NV: Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg 124: 1432-1435, 1989.
8. 2, nitric oxide and superoxide by macrophages. J Trauma 37:82-90, 1994.
9. Ziegler-Heirbrock HWL: Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45:13-26, 1995.
10. West MA, Bennett T, Scatter SC, Clair L, Bellingham J: LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kinase activation. J Leuk Biol 61:88-95, 1997.
11. Chen H, Halushka PV, Cook JA: Endotoxin tolerance: Effects on lethality and macrophage thromboxane and interleukin-6 production. Shock 1:366-371, 1994.
12. Knopf H-P, Otto F, Engelhardt R, et al: Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and synthestic lipid A analogue DSZ MRL 953. J Immunol 153:287-299, 1994.
13. Seatter SC, Clair L, Bennett T, Bubrick MP, West MA: Independent signal transduction pathways for IL-1 and TNF in LPS-tolerant macrophages. J Surg Res 58:651-658, 1995.
14. Sweet MJ, Hume DA: Endotoxin signal transduction in macrophages. J Leuk Biol 60:8-26, 1996.
15. Wright SD: CD14 and innate recognition of bacteria. J Immunol 6-8: 1995.
16. Weinstein SL, June CH, DeFranco AL: Lipopolysacchride-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J Immunol 151:3829-3838, 1993.
17. Reimann T, Büscher D, Hipskind RA, Krautwald S, Lohmann-Mathes M-L, Baccarini M: Lipopolysaccharide induces activation of the Raf-1/ MAP kinase pathway: A putative role for Raf-1 in the induction of the IL-1β and the TNF-α genes. J Immunol 153:5740-5749, 1994.
18. Liu MK, Herrera-Velit P, Browney RW, Reiner NE: CD14-dependent activation of protein kinase C and mitogen-activated kinases (p42 and p 44) in human monocytes treated with bacterial lipopolysaccharide. J Immunol 153: 2642-2652, 1994.
19. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811, 1994.
20. Pelech SL, Sanghera JS: MAP kinases: Charting the regulatory pathways. Science 257:1355-1356, 1992.
21. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T: The stress-activated protein kinases are major c-Jun amino terminal kinases activated by ischemia and reperfusion. J Biol Chem 269:26546-26551, 1994.
22. d phenotype. J Exp Med 164:1791-1796, 1986.
23. d) macrophages requires the presence of lipid A-associated proteins. J Immunol 141:4196-4202, 1988.
24. d) macrophages. J Immunol 153:2653-2663, 1994.
25. Ding A, Hwang S, Lander HM, Xie Q-W: Macrophages derived from C3H/HeJ (Lps) mice respond to bacterial lipopolysaccharide by activating NF-κB. J Leuk Biol 57:174-179, 1995.
26. Tanamoto K-i, Azumi S, Haishima Y, Kumada H, Umemoto T: The lipid A moiety of Prophyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice. J Immunol 158:4430-4436, 1997.
27. Shinomiya H, Hirata H, Nakano M: Purification and characterization of the 65-kDa protein phosphorylated in murine macrophages by stimulation with bacterial lipopolysaccharide. J Immunol 146:3617-3625, 1991.
28. Aggarwal BB: Human Lymphotoxin. Methods Enzymo 116:441-448, 1985.
29. Mathison J, Wolfson E, Steinemann S, Ulevitch R: Lipopolysaccharide (LPS) recognition in macrophages: Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages. J Clin Invest 92:2053-2059, 1993.
30. Hailman E, Lichenstein HS, Wurfel MM, et al: Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179:269-277, 1994.
31. Perea P-Y, Vogel SN, Detore GR, Haziot A, Goyert SM: CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J Immunol 158:4422-4429, 1997.
32. Shinji H, Akagawa K, Yoshida T: LPS induces selective translocation of protein kinase C-β in LPS-responsive mouse macrophages, but not in LPS-nonresponsive mouse macrophages. J Immunol 153:5760-5771, 1994.
33. Takasuka N, Matsuura K, Yamamoto S, Akagawa KS: Suppresion of TNF-α mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-κB activation, but not at the level of protein kinase C or CD14 expression. J Immunol 154:4803-4812, 1995.
34. Kraatz J, Clair L, Bellingham J, Wahlstrom K, Rodriguez JL, West MA: Lipopolysaccharide pretreatment produces macrophage (Mφ) endotoxin tolerance via a serum-independent pathway. J Trauma 45:684-691, 1988.
35. Chapes SK, Killion JW, Morrison DC: Tumor cell killing and cytostasis by C3H/HeJ macrophages activated in vitro by lipid A-associated protein and interferon gamma. J Leuk Biol 43:232-237, 1988.